glp-1 receptor agonist dry eye The use of agonists was associated with a substantially lower long-term risk for age-related macular degeneration than the use of other weight-loss medications in adults with overweight or obesity GLP-1 Drugs and Diabetic Eye

[BALANCE, better approaches to lifestyle and nutrition for comprehensive health, is intended to lower prices by having the Centers for Medicare and Medicaid Services negotiating pricing directly with drug-makers.] Medicare GLP-1 Bridge runs from July 1st, 2026, all the way through December 31st, 2027

The funder of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

doi: 10.1001/jama.2024.2252 21 ZakariaHAlshehhiSCaccelliMOzkanCKattanJJafaarZet al

However, the Author has not independently verified or otherwise investigated all such information

TRANSCEND-T2D-1 (NCT06354660) will compare the efficacy and safety of retatrutide compared to placebo in people with inadequately controlled T2D treated with diet and exercise over a period of 11 months

Finally, preclinical data suggest that treatment with GLP-1 RAs could result in lower incidence of NASH-related hepatocellular carcinoma (HCC) [100]